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Background: Beclin1 is a well-known key regulator of autophagy, which is also a haploinsufficient tumor
suppressor. Current studies revealed that down-regulation or monoallelic deletions of Beclin1 were frequently
found in various cancers. The purpose of this study was to investigate the effects of Beclin1 inhibition on
autophagy and Gemcitabine-induced apoptosis of pancreatic cancer cells.
Methods: Beclin1 expression was inhibited by siRNA transduction and gene expression was determined by Real-
time PCR and Western blot. The effects of Beclin1 inhibition on autophagy and Gemcitabine-induced apoptosis of
Miapaca2 cells were analyed through LC3 expression, cell viability, cell cycle and apoptosis by using Western blot.
Results: We observed that Beclin1 silence promoted microtubule-associated protein 1 light chain 3-II (LC3-II)
protein formation and increased punctate fluorescent signals in Miapaca2 cells transfected with green fluorescent
protein (GFP)-tagged LC3. Beclin1 inhibition showed a greater suppressive effect on Gemcitabine-induced apoptosis
of Miapaca2 cells.
Conclusion: Our data suggested that Beclin1 silence not only up-adjusted autophagy process, but also played an
important role in the regulation of apoptosis. Beclin1 inhibition could inhibit apoptosis signaling induced by
Gemcitabine in Miapaca2 cells.Background
Autophagy is an evolutionary conserved process in which
cell engulfs cytoplasmic constituents within a double-
membrane vacuole (termed autophagosome) and delivers
them to the lysosome for degradation. Autophagy contri-
butes to maintain cellular homeostasis as a result of qual-
ity control of both proteins and organelles [1-3]. In
addition to its basic role in the turnover of proteins and
organelles, autophagy has multiple physiological and
pathophysiological functions including supply of nutrients
and energy for cell survival and protection of cells against
environmental stress [4,5]. Some evidences demonstrate
that increased numbers of autophagosomes have been as-
sociated with forms of non-apoptotic cell death [6,7], that
is distinct from apoptosis, a form of cell suicide mediated
by caspase activation. Autophagy plays an important role* Correspondence: guoxiaozhong1962@163.com; wanghualjh@gmail.com
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reproduction in any medium, provided the orin the modulation of cancer development and in the
determination the response of many cancer cells to pro-
apoptotic-related chemotherapy. The functional relation-
ship between apoptosis and autophagy is complicated.
Beclin1 is a phylogenetically conserved protein that is
essential for autophagy. In fact, the first association be-
tween autophagy and cancer was the landmark discovery
of Beclin1, which is also a haploinsufficient tumor sup-
pressor [1]. Current studies revealed that down-regulation
or monoallelic deletions of Beclin1 were frequently found
in various cancers including human breast carcinoma,
oophoroma, prostatic carcinoma and others [8-10]. Ac-
cordingly the expression of Beclin1 may play an important
role in tumorigenesis.
The therapeutic goal of cancer treatment is to trigger
tumor-selective cell death. Pancreatic cancer, a highly le-
thal disease, is usually diagnosed at an advanced stage for
which there is little or no effective therapy. Gemcitabine,
an anti-cancer chemotherapeutic drug which affects cell
cycle and causes apoptosis, is an important option inhis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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cancer. Gemcitabine offers both symptomatic and survival
benefits for pancreatic carcinoma. Emerging evidences
have shown that autophagy plays an important role in the
regulation of chemosensitivity to anti-cancer drugs and af-
fects proliferation in some cancer cells. However, the role
of Beclin1 in regulation of Gemcitabine-induced autoph-
agy and apoptosis remain unclear.
In this study,we examined the autophagy of human
pancreatic cancer Miapaca2 cells transduced with Beclinl-
siRNA. Meanwhile the relationship between Beclinl inhib-
ition and Gemcitabine induced apoptosis were detected in
Miapaca2 cells.
Methods
Cell lines and cell culture
The human pancreatic cancer Miapaca2 cells were
obtained from Beijing Institute of Radiation Medicine.
Cells were cultured with Dulbecco’s modified Eagle’s
medium (DMEM; Sigma, St. Louis, MO, USA) supple-
mented with 10% fetal bovine serum (FBS; Hyclone,
USA). Cultures were incubated in a humidified atmos-
phere of 95% air and 5% CO2 at 37°C.
RNA interference of Beclin1
Miapaca2 cells were seeded in 24-well plates (1.5 × 105
cells per well) and incubated overnight. A negative control
random small interfering RNA (NC-siRNA) or Beclin1-
targeted siRNA (1 μg/well) was transfected by using
Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA)
according to the manufacturer’s protocol. After 48 h
transfection, cells were collected and cell lysates were
subjected to immunoblotting of Beclin1. Beclin1-siRNA,
NC-siRNA and FAM-siRNA were provided by Shanghai
Genepharma Co., Ltd. The negative control sequence was
GTTCTCCGAACGTGTCACGT. The interfering se-
quence of Beclin1 was GCTGCCGTTATACTGTTCT.
Western blot analysis of Beclin1
After transfection, the Miapaca2 cells were washed twice
with PBS, and lysed with a solution containing Tris–HCl
(50 mmol/L, pH 6.8), SDS (10% w/v), glycerol (10%), and
dithiothreitol (10 mmol/L), supplemented with protease
inhibitor mix. Cell lysates were centrifuged at 12,000 g for
20 min. Equal amounts of the protein were suspended in
5×Laemmli buffer and resolved by SDS–PAGE and trans-
ferred onto a PVDF membrane. After blocking with 5%
non-fat dry milk in TBS for 1 h at room temperature,
membranes were washed 3 times and incubated for 1 h
with anti-Beclin1 antibody (Sinopharm chemical Reagent
Co. Ltd, China) at room temperature then at 4°C over-
night. Then the PVDF membrane was treated with a
horseradish peroxidase-conjugated anti-rabbit IgG anti-
body (Santa Cruz Biotechnology, CA, USA) for 45 minutesat room temperature. Specific bands were detected by an
enhanced chemiluminescence system (Pierce, Rockford,
IL, USA). Anti-β-Actin (Santa Cruz Biotechnology, CA,
USA) was used to ensure equal loading. Band intensity
was semi-quantified using Scion Image software after con-
version to digitalizing image using an image scanner
(GT9700F; Epson, Tokyo, Japan).
Real-time analysis of Beclin1 gene
The primers were designed by Primer premier 5.0 soft-
ware and synthesized by Shanghai Invitrogen Co. Ltd.
China. Beclin1 forward sequence (50to30): GGTGTCTCTC
GCAGATTCATC; Beclin1 reverse sequence (50to30): TC
AGTCTTCGGCTGAGGTTCT. Total RNA was prepared
from Miapaca2 cells transfected with Beclin1-siRNA or
NC-siRNA according to the manufacturer’s instructions
and the concentration of total RNA was determined.The
RNA was then reversely transcribed in a 20 μL reaction
mixture according to the instructions of RevertAid First
strand cDNA syntherio Kit (Fermentas, China).The PCR
program for Beclin1 and GAPDH (Santa Cruz Biotechnol-
ogy, CA, USA) included one cycle at 95°C for 2 min, 39 -
cycles at 95°C for 20 s,65°C for 20 s, 72°C for 30 s, and
finally extension at 72°C for 10 min, the PCR products of
Beclin1 gene and internal controls were detected by elec-
trophoresis in agrose gel.
Western blot analysis of LC3-.alpha;
After transfection of Beclin1-siRNA or NC-siRNA for
48 h, the Miapaca2 cells were treated as previous process
described to detect expression of LC3-;α protein with
anti-LC3 antibody (MBL International) and anti-rabbit
IgG antibody (Santa Cruz Biotechnology, CA, USA).
Involvement of LC3
PEGFP-LC3 plasmid was kindly gifted by professor
Noboru Mizushima and Tamotsu Yoshimori (Tokyo
Dentistry University). Miapaca2 cells were plated in
24-well plates (1.5 × 105 cells/well) and transfected with
PEGFP-LC3 plasmid and Beclin1-siRNA or NC-siRNA
plasmid by using the Lipofectamine 2000. After 48 h
transfection, cells were washed with PBS and perme-
abilized with 0.1% TritonX-100 for 10 min, staining
with DAPI (1:10 dilution with buffer fluid) for 10 min.
Then autophagosome in cells were observed through
green fluorescent protein (GFP) in cells by Confocal
laser scanning microscope (Zeiss LSM510, German).
Cell viability measurement
Cell viability was deteced by Cell Counting Kit-8 (CCK8,
Dojindo Molecular Technologies, Kumamoto, Japan).
After transfection with Beclin1-siRNA or NC-siRNA for
24 h, Miapaca2 cells were seeded in 96-well plates at a
density of 5×103 cells/well and incubated, Untreated
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put into each well after transfection for 30 h, 48 h, 72 h
and 96 h, then the cells were incubated in a humidified
5% CO2 atmosphere at 37°C for 1 h. The absorbance of
the solution was read spectrophotometrically at 450 nm
through a microtitre plate reader (Thermo Varioskan
flash, USA). Cell viability was calculated according to the
following formula: cell viability (%) = A450 (tested group -
blank group)/A450 (control group - blank group) × 100%.
Three replicates were performed for each treatment.
Analysis of the cell cycle
Miapaca2 cells were transfected with corresponding
plasmids in 24-well plates and incubated for 24 h. Then
cells were exposed to adequate density of Gemcitabine
(3 μg/ml). After 24 h of treatment, cells were harvested
by trypsinization, washed twice in cold PBS. Then fixed
with cold 70% ethanol, and stored at 4°C until analyzed.
The cells were resuspended in PBS added 2 μL of
RNaseA (10 mg/mL), Propidium iodide (final concentra-
tion, 50 μg/mL; BD,USA), then incubated at 4°C in the
dark for 20 min, and DNA content was detected by flow
cytometry (BD FACSCalibur, USA). The relative propor-
tions of cells in the G2/G1and S phases of the cell cycle
were determined from the flow cytometry data.
Apoptosis detection by flow cytometry
Miapaca2 cells were transduced with corresponding
plasmids in 24-well plates and incubated for 24 h. Then
cells were exposed to adequate density of Gemcitabine
(3 μg/ml). After 24 h of treatment, cells were harvested by
trypsinization, washed twice with cold PBS. After staining
with the combination of AnnexinV/fluorescein isothio-
cyanate (FITC) and propidium iodide (PI) (Annexin-V:
FITC Apoptosis Detection Kit, BD Pharmingen), the cells
were immediately analyzed by flow cytometry.
Statistical analyses
All statistical analyses were performed using SPSS11.5
software. The results expressed as means ± SD and were
compared using Student’s t test to determine statistical
significance between control and test groups. p < 0.05
was considered statistically significant.
Results
SiRNA inhibition of Beclin1 expression by Miapaca2 cells
The Miapaca2 cells were transduced with recombinant
GFP plasmid and the transfection efficiency was observed
by fluorescence microscope. More than 80% of the cells
exhibited positive fluorescent signals under an inverted
fluorescence microscope (Figure 1A). To observe the effect
of Beclin1 inhibition in siRNA transduced Miapaca2 cells,
Western blotting was performed to analyze the expression
level of Beclin1 protein (Figure 1B). Real-time PCR wasalso applied to detect Beclin1 mRNA expression recur to
comparison of Delta-delta Ct means (Figure 1C). Compar-
ing to NC-siRNA group, less quantity of Beclin1 protein
and Beclin1 mRNA were detected in the Beclin1-siRNA
transfected Miapaca2 cells. From three Beclin1-siRNA se-
quences provided, Beclin1-siRNA3 was preferably se-
lected to apply in the following experiment. Further the
recombinant plasmids pGPU6/Neo-shBECN1, pGPU6/
Neo-shNC and pGPU6/GFP/Neo-shNC were constructed
by Shanghai Genepharma Co., Ltd in order to stably trans-
fect cells.Beclin1 inhibition increases LC3-II protein expression and
formation of autophagosome in Miapaca2 cells
In order to determine whether down-regulation of Beclin1
played a role in regulation of autophagy, we initially deter-
mined a change in the expression level of the microtubule-
associated protein 1 light chain 3 (LC3)-II, a marker for
the presence of autophagosomes, in the Beclin1-siRNA
transduced Miapaca2 cells by immunoblot analysis. As
shown in Figure 2A, the amount of LC3-II was found in-
creased in Beclin1-siRNA transduced Miapaca2 cells as
compared to negative control (NC-siRNA) (p < 0.05), and
LC3-I was decreased accordingly (p < 0.05).
In addition, autophagic change of cells expressing
GFP-LC3 was also observed. Recruitment of LC3-II to
the autophagosomes is characterized by punctate pattern
of its localization. The NC-siRNA transduced Miapaca2
cells displayed diffuse and weak LC3-associated green
fluorescence. However, the Beclin1-siRNA transduced
Miapaca2 cells showed characteristic punctate LC3-
associated green fluorescence as shown in Figure 2B (a, b).
These results indicated that inhibition expression of
Beclin1 was able to promote autophagosome formation in
Miapaca2 cells.Effect of Beclin1 down-regulation on proliferation of
Miapaca2 cells
Autophagy is recognized as a cytoprotective process
against environmental stress and maintaining cellular
homeostasis. We sought to determine the effect of au-
tophagy enhancement by Beclin1-siRNA on cell prolifer-
ation. First, the Miapaca2 cells transfected with pGPU6/
Neo-shBECN1 were selected with G418 (400 μg/ml),
then the steady lower-expression of Beclin1 was con-
firmed by western blot (Figure 3A,B). We examined the
proliferation patterns of the transfected cells by CCK8
kit. As shown in Figure 3C, there was not significant
variation in the viability of the Beclin1-siRNA trans-
duced Miapaca2 cells compared to that of NC-siRNA
cells. The results showed that there was no significant
influence of inhibition expression of Beclin1 on the pro-
liferation of Miapaca2 cells as well.
Figure 1 Detection of Beclin1 expression in Beclin1-siRNA transfected Miapaca2 cells. A. Miapaca2 cells transfected with FAM-siRNA for 6 h
exhibited green fluorescent signals under an inverted fluorescence microscope. B. Beclin1 protein expression analysis through Western blotting.
Cytoplasmic protein was extracted from the cells of negative control siRNA (NC-siRNA) transfectant and Beclin-siRNA transfectant. The results are
representative of at least three independent experiments. Beclin-siRNA3 was found the preferable sequence. **p < 0.01 vs NC-siRNA group. The
Student’s t-test was used to analyze the data. C. Beclin1 mRNA expression analysis through real-time PCR, GAPDH was used to ensure equal
loading. ** p < 0.01 vs NC-siRNA group. The Student’s t-test was used to analyze the data.
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Miapaca2 cells
In order to observe the effect of autophagy enhancement
by Beclin1-siRNA on apoptosis in human pancreatic
cancer Miapaca2 cells, the cell apoptosis was stained
with Annexin V-FITC and determined by flow cytome-
try. The results showed that there was no obvious
variation of the Annexin V expression in Beclin1-siRNA
transduced cells compared to that of NC-siRNA trans-
duced cells (Figure 4A). That indicated the autophagy
reinforced by down-regulation of Beclin1 had less influ-
ence on the apoptosis of Miapaca2 cells.
In addition, the effect of down-regulation of Beclin1
on Miapaca2 cells cycle was observed. As shown in
Figure 4B, the percentage of Beclin1-siRNA transduced
Miapaca2 cells in the G2 phase was (7.00 ± 2.82)% com-
pared with (7.92 ± 2.56)% of the NC-siRNA cells, and
the percentage of the S phase was (9.20 ± 0.22)% com-
pared with (10.93 ± 0.19)% accordingly (p < 0.01). These
results indicated that autophagy reinforced by down-
regulation of Beclin1 had a significant influence on cell
cycle arrest of Miapaca2 cells.Down-regulation of Beclin1 decreases the cytotoxic
sensitivity of Miapaca2 cells to gemcitabine
To confirm the effect of autophagy reinforced by Beclin1
inhibition on the cytotoxic sensitivity of Miapaca2 cells,
the apoptosis and cell cycle of cells treated with
Gemcitabine were analyzed. Gemcitabine alone or plus
Beclin1-siRNA induced apoptosis which was determined
Annexin V-FITC staining. The results suggested that
apoptosis was significantly decreased in Miapaca2 cells
treated with Gemcitabine plus Beclin1-siRNA than that
of drugs alone (Figure 5A).
Accordingly, Gemcitabine alone or drugs plus Beclin1-
siRNA treated cells were analyzed for changes of cell cycle
by flow cytometry. As shown in Figure 5B, the percentage
of Beclin1-siRNA combining with Gemcitabine treated
cells in G2 phase was significantly increased to (6.46 ±
1.91)% in compared with (0.01 ± 0.00)% of Gemcitabine
alone treated cells, while the percentage of Beclin1-siRNA
combining with Gemcitabine treated cells in the S phase
was significantly decreased to (18.48 ± 0.28)% com-
pared to (29.00 ± 0.45)% of the drugs alone treated
cells (p< 0.01), which indicated that Beclin1 inhibition affected
Figure 2 Inhibition expression of Beclin1 increases LC3-II protein expression and formation of autophagosome in Miapaca2 cells. A.
Beclin1 inhibition increased autophagy in Miapaca2 cancer cells. Western blot analysis of the LC3, Beclin1 expression in Miapaca2 cells transfected
with Beclin1-siRNA and NC-siRNA for 48 h. β-Actin was used to ensure equal loading. B. Confocal laser scanning microscope for analysis of
punctate pattern of LC3 localization in the cells transiently transfected with the GFP-LC3-vector and treated vehicle (Beclin1-siRNA) or control
(NC-siRNA) for 48 h. The cells were stained with DAPI. (a:Miapaca2 cells transfected with NC-siRNA; b:Miapaca2 cells transfected
with Beclin1-siRNA).
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phase. These results demonstrated that down-regulation of
Beclin1 was disadvantageous to survival inhibition of
Miapaca2 cells induced by chemotherapeutic anti-cancer
drugs Gemcitabine.
Discussion
Autophagy is a physiologic process that plays an import-
ant role in the turnover of cellular proteins and other
macromolecules to maintaining cellular homeostasis.
There are nearly 30 autophagy-related proteins (ATGs) in
mammals, and these have been identified based on investi-
gations in yeast [1]. ATGs, through their roles in signaling
pathways, maintain normal physiological levels of autoph-
agy. The autophagy process occurs sequentially in phases:
induction, phagophore formation, autophagosome elong-
ation, autolysome formation, and then degradation. Dur-
ing the autophagosome elongation phase, two conjugationsystems are indispensable for the formation of the
autophagosome. The first one is Atg5-Atg12 conjugates,
which are localized to phagophores and dissociate after
mature autophagosomes are formed [11]. Atg5-Atg12
conjugation is regulated by the activity of the class III
PI-3-kinase, Vps34 [12]. Vps34 activity is positively regu-
lated by the mammalian orthologue of yeast Atg6, Beclin1
[13]. The second is modification involves conjugation of
microtubule associated protein 1 light chain 3 (MAP–
LC3/Atg8/LC3) to phosphatidylethanolamine (PE). LC3
(cytosolic) is cleaved at its C terminus by Atg4 to form
LC3-I. LC3-I is covalently conjugated to PE to form LC3-
II. LC3-II (membrane associated) is specifically targeted to
Atg5–Atg12-associated, expanded phagophores and re-
mains associated with autophagosomes even after fusion
with lysosomes, after which LC3-II can be delipidated and
recycled. LC3 is the only known protein that specifically
associates with autophagosomes and not with other
Figure 3 Effect of down-regulation of Beclin1 on proliferate viability in Miapaca2 cells. A. Miapaca2 cells transfected with pGPU6/GFP/Neo-
shNC for 24 h by Lipofectamine 2000 exhibited green fluorescent signals under an inverted fluorescence microscope. B. Miapaca2 cells were
stably transfected with pGPU6/Neo-shBECN1 or pGPU6/Neo-shNC for 48 h, then exposed to G418 (400ug/ml) for 18 days. Western blot analyze of
the Beclin1 expression. C. Small RNA interference of Beclin1 had not obvious influence on survival of Miapaca2 cells in 96 h. Cell viability was
determined by the Cell counting Kit-8 assay. The difference was not significant between Beclin1-siRNA group and NC-siRNA group (p > 0.05).
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autophagosome number, which can also be assessed by
scoring LC3-positive vesicles [14]. From above, we have
known that Beclin1 mediates the accumulation of ATGs
such as Atg5-Atg12 conjugation system and Atg8/LC3
conjugation system locating in pre-autophagosomal struc-
tures (PAS), which is essential for the formation of the au-
tophagic vesicle and performs a key role in triggering
autophagy and its applications in phagophore formation.
Many observations have confirmed that expression of
Beclin1 regulates coincidentally autophagy process. Beclin1
over-expression consistently increased autophagosome
numbers [15]. Conversely, Beclin1-deficient mice show a
pronounced loss of autophagic vacuole formation.Homo-
zygous Beclin1 null mice die during early embryogenesis
and heterozygous Beclin1+/−mice show a high incidence
of spontaneous tumors [16]. Similarly, the knockdown
of Beclin1 inhibits autophagy and sensitizes cells to
starvation-induced cell death [17]. However, the expression
and roles of Beclin1 may be different in tumor cells. In our
studies, the results were interestingly showed that quantity
of LC3-II protein and autophagosome synthesis weresignificantly increased after Beclin1 had been inhibited
through small interfering RNA against beclin1, it meant
that Beclin1 inhibition could promote autophagy in human
pancreatic cancer cells Miapaca2. The probable mecha-
nisms are assumed that there could be an undiscovered
important protein regulating the autophagy process, a pos-
sible negative feedback or two-way regulation mechanism
played a role when expression of Beclin1 was inhibited.
The activity of the protein was associated with Beclin1,
meanwhile, it should induce accumulation of Atg5-Atg12
conjugation system and Atg8/LC3 conjugation system in
pre-autophagosomal structures, accordingly promote au-
tophagy process. The probable mechanism interests us
extremely and that will be our further studies later on. In
addition, Beclin1 is part of the type III PI3 kinase complex
that is required for the formation of the autophagic vesicle
and interacts with Bcl-2. It also interacts with the other
major anti-apoptotic Bcl family protein (Bcl-xL). Autoph-
agy can be regulated by this interaction. Inhibiting apop-
tosis by binding to and interfering with the action of the
pro-apoptotic proteins, Bax and Bak, Bcl-2/Bcl-xL also in-
hibits autophagy by binding with Beclin1. On the basis of
Figure 4 Effect of down-regulation of Beclin1 on apoptosis and cell cycle in Miapaca2 cells. A. Apoptosis was determined by flow
cytometry for annexin-V-FITC and propidium iodide (PI) dual labeling. Cytograms of annexin-V-FITC binding (abscissa) versus PI uptake (ordinate)
show three distinct populations: (1) viable cells in gate Q3; (2) early apoptotic cells in gate Q4; and (3) cells that have lost membrane integrity as
a result of very late apoptosis in gate Q2. Percentage of apoptotic cells is gate Q4 plus gate Q2. The apoptotic rate was similar in Beclin1-siRNA
transfection Miapaca2 cells (0.01 ± 0.00)% compared with (0.00 ± 0.00)% of NC-siRNA. B. Cell cycle was also determined by flow cytometry. The
percentage of Beclin1-siRNA transfected Miapaca2 cells in the G2 phase was (7.00 ± 2.82)% compared with (7.92 ± 2.56)% of NC-siRNA; (83.80 ±
2.60)% compared with (81.15 ± 2.75)% in the G1 phase, and in the S phase was (9.20 ± 0.22)%compared to (10.93 ± 0.19)% accordingly (p < 0.01).
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the undiscovered important protein regulating the autoph-
agy process could interact with apoptosis/Bcl-2 or Bcl-xL.
Besides, the role of autophagy could depend on the type of
tumor, the stage of tumorigenesis, and the nature and ex-
tent of the insult in tumor cells. The precise and compli-
cated mechanisms underlying the autophagy process are
still ambiguous and the further researches are essential to
determine.
Recently, a large number of studies on the interconnec-
tion between Beclin1, autophagy and tumorigenesis have
been analyzed. Numerous observations have demon-
strated that Beclin1 has been implicated in tumorigenesis,
and plays a role in cellular proliferation. A study also
found that the protein level of Beclin1 is lower in cervical
cancer tissues than in normal tissues, and is closely related
to pelvic lymph node metastases and histologic tumor
grade [18]. Heterozygous disruption of Beclin1 in mice
results in reduced autophagy, increased cellular prolifera-
tion, and spontaneous malignancies [16]. But the molecu-
lar mechanism underlying this relationship is still obscure.
Pancreatic adenocarcinoma is one of the most lethal hu-
man malignancies, it doesn’t respond well to traditionalchemotherapy and radiotherapy, leaving little effective
treatment for advanced pancreatic cancer cases. The pre-
cise complicated mechanisms of insensitivity to therapy
are still uncertain completely. Gemcitabine is a widely
used chemotherapeutic anti-cancer drug that is effective
in the treatment or controlling of a variety of human can-
cers including pancreatic cancer. Its action is cell phase
specific (S-phase) and, under certain circumstances, block
the progression of cells through the G1/S-phase boundary.
The cytotoxic actions of Gemcitabin in vitro are concen-
tration and time dependent. Its cytotoxic effect is due to
DNA synthesis inhibition leading to induce apoptosis. In
our studies, we proceeded to dissect the contributions of
autophagy to the survival of Miapaca2 cells during
Gemcitabine-induced apoptosis. The findings suggested
down-regulation of Beclin1 increased autophagy, and
accordingly inhibited Gemcitabine-induced cell apoptosis
in Miapaca2 cells. In addition, that stimulated the pro-
gression of cells through the S/G2 phase boundary.
Gemcitabine-treated Miapaca2 cells in the G2 phase was
significantly increased. According to the present results,
we deduced the conclusions that autophagy participated
apoptosis process and decreased apoptotic response
Figure 5 Down-regulation of Beclin1 decreases the cytotoxic sensitivity of Miapaca2 cells to Gemcitabine. A. After transfection of vector
for 24 h then 24 h of drug incubation in Miapaca2 cells, majority cells went to death. Apoptosis was determined by flow cytometry. The
apoptotic rate was significantly decreased to (0.06 ± 0.00)% compared with (29.13 ± 0.47)% of non- drug-treated cells (p < 0.01). B. Cell cycle was
analyzed by flow cytometry. The percentage of Miapaca2 cells treated with Beclin1-siRNA plus drug in the G2 phase was (6.46 ± 1.91)% compared
with (0.01 ± 0.00)% of NC-control cells; (75.07 ± 1.63)% compared with (71.00 ± 0.45)% in the G1 phase, and in the S phase was (18.48 ± 0.28)%
compared to (29.00 ± 0.45)% accordingly (p < 0.01).
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while it interfered cell cycle distribution of Miapaca2
cells treated with Gemcitabine, therapeutical effect of
Gemcitabine was weakened on Miapaca2 cells in which
the expression of Beclin1 was inhibited. Accidentally, an
interesting result as Figure 5B shown was found in our
experiment, the massive 3-fold increase in cells in the S-
Phase of the cell cycle after treatment with non-specific
siRNA and gemcitabine. That was departed from the
effect of blocking the progression of cells through the G1/
S-phase boundary of Gemcitabine. We conjecture that
treatment with non-specific siRNA could obstruct the
action of Gemcitabine in cell phase specific. The undis-
covered mechanism perplexed us and it is necessary to re-
search intensively. A study demonstrated that Beclin1 was
not only necessary for the formation of the autophagic
vesicle, but also interacted with Bcl-2, an anti-apoptotic
protein. And it also interacted with the other major anti-
apoptotic Bcl family protein (Bcl-xL) which demonstrated
that autophagy could be regulated by this interaction. In
addition to inhibiting apoptosis by binding to and interfer-
ing with the action of the pro-apoptotic proteins, Bax andBak, Bcl-2/Bcl-xL also inhibits autophagy by binding with
Beclin1[19].
Newly published work by Saleem A et al. showed that
therapeutic inhibition of autophagy with hydroxychlo-
roquine (HCQ) increased cytotoxicity of small molecule
BH3 domain mimetics such as ABT-737 both in vitro and
in vivo [20]. All these results demonstrated potential infor-
mation that there are possibly precise complicated mecha-
nisms and close correlation between autophagy and the
apoptosis in cancer cells. Further research is necessary for
tumor cells to anticancer therapy.
Conclusion
In conclusion, our data indicated Beclin1 inhibition
promoted autophagy in human pancreatic cancer cells
Miapaca2. It also demonstrated that Beclin1 not only ad-
justed autophagy process, but also played an important
role in the regulation of apoptosis. Beclin1 inhibition
could inhibit apoptosis signaling induced by Gemcitabine
in Miapaca2 cells. It will be helpful for human to adopt
anticancer therapy if the complicated mechanisms could
be discoverd in cancer cells.
Li et al. Cancer Cell International 2013, 13:26 Page 9 of 9
http://www.cancerci.com/content/13/1/26Abbreviation
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